Author Question: A level 1 heading should be a. flush left with upper and lower case letters b. flush left, ... (Read 233 times)

jilianpiloj

  • Hero Member
  • *****
  • Posts: 521
A level 1 heading should be
 
  a. flush left with upper and lower case letters
  b. flush left, boldface, with upper and lower case letters
  c. centered, boldface, in upper and lower case letters
  d. flush right, boldface, all upper case letters

Question 2

A weakness of the mixed methods approach is that
 
  a. divergent aspects of a phenomenon cannot be studied.
  b. it can be difficult to connect theory to practice.
  c. it is an old methodology with few people using it.
  d. because expertise is needed to two areas it can be difficult to find people qualified to perform both types research.



chereeb

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

C

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library